|
HS Code |
406537 |
| name | Catharanthine |
| chemical_formula | C21H24N2O2 |
| molecular_weight | 336.43 g/mol |
| CAS_number | 483-18-1 |
| appearance | White to pale yellow solid |
| melting_point | 126-127°C |
| solubility | Soluble in chloroform, sparingly soluble in water |
| source | Extracted from Catharanthus roseus (Madagascar periwinkle) |
| IUPAC_name | (3α,16β,19α)-16,17-didehydro-3,4,5,6,16,17-hexahydro-1H,12H-indolo[3,2-a]pyrrolo[3,4-c]quinolizin-1-one |
| PubChem_CID | 10134 |
| pKa | 8.88 |
| storage_conditions | Store at -20°C, protected from light |
As an accredited Catharanthine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Catharanthine is provided in a sealed amber glass vial containing 100 mg, clearly labeled with product name, quantity, and safety information. |
| Shipping | Catharanthine is shipped in tightly sealed containers to protect it from light and moisture. It is handled as a hazardous chemical, typically transported according to relevant regulations for laboratory reagents. Proper labeling, documentation, and packaging ensure safety during transit, with temperature controls maintained as specified in the material safety data sheet (MSDS). |
| Storage | Catharanthine should be stored in a cool, dry, and well-ventilated area, away from direct sunlight and sources of heat or ignition. Keep the container tightly closed and properly labeled. Store at temperatures between 2–8°C (refrigerated conditions) and protect from moisture. Ensure segregation from incompatible substances, particularly strong oxidizers, and follow appropriate laboratory safety protocols at all times. |
Applications of Catharanthine in Industrial ManufacturingCatharanthine, a well-defined monoterpenoid indole alkaloid, serves as a crucial intermediate in several high-value pharmaceutical and chemical processes. As a committed manufacturer, we supply catharanthine for use only in mature, controlled, and compliant industrial supply chains. Below, we outline the key application scenarios with process-specific information, typical formulation guidance, quality compliance requirements, and the nature of downstream finished goods. 1. Anticancer Alkaloid API Synthesis (Vinblastine, Vincristine Production)Major pharmaceutical manufacturers incorporate catharanthine as a starting intermediate in the semi-synthetic production of vinca alkaloid anticancer drugs. This process requires careful handling and consistent material quality, as the alkaloid core of catharanthine undergoes dimerization with vindoline under strictly controlled parameters. Only pharmaceutical operations with validated chemistry and GMP-compliant facilities handle this route, due to the potent activity and regulatory complexity of the drugs derived. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Advanced Chemical Research and Standard Material SupplyResearch-grade catharanthine is critical in advanced discovery chemistry, serving both as control material for analytical method validation and as a building block for synthetic projects aiming to generate novel alkaloid analogues. Industrial research laboratories, as well as academic chemistry departments partnering in pre-clinical pharmaceutical pipeline development, use high-purity catharanthine for method calibration, reference standard preparations, and early stage molecule discovery. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Intermediates for Semi-Synthetic Alkaloid DerivativesChemical manufacturers specializing in high-value biogenic intermediates deploy catharanthine as a precursor for the generation of novel semi-synthetic derivatives. These derivatives are evaluated for potential pharmaceutical applications or used to extend the alkaloid scaffold for further chemical transformations within industrial medicinal chemistry workflows. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Biotechnology-Based Biotransformation SubstrateCatharanthine serves as a valuable substrate for industrial-scale biotransformation applied by companies focusing on enzyme or microbial catalysis of alkaloids. Controlled feed of this material supports production of advanced derivatives under mild processing, using genetically engineered microorganisms or isolated enzymes, driving greener chemistry trends in pharmaceutical and specialty chemical sectors. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Catharanthine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Catharanthine has held a special place in the world of specialty chemicals, especially for those of us who spend our careers in the manufacturing sector. Anyone can talk about a molecule’s theoretical properties, but from the perspective of a producer who has spent years developing the craft, the value and challenge of making catharanthine run much deeper than any regulatory label or catalog SKU. Our teams have faced everything from raw material shortages to picky purity requirements, all in the pursuit of a reliable, high-quality product.
Catharanthine stands as an essential monoterpenoid indole alkaloid. Extracted and refined in our facilities, its journey starts with the leaves of Catharanthus roseus and arrives in labs worldwide. During production, we balance delicate extraction and isolation steps, since impurities often seem eager to sneak into every batch. Through much trial, error, and refinement, our output has reached a consistency that allows us to ship to pharmaceutical R&D departments that expect nothing short of excellence.
We often get asked about the model or grade we offer. Our catharanthine reaches a purity of more than 98%, verified batch after batch with HPLC, NMR, and mass spectrometry. It arrives as an off-white crystalline powder, typically in sealed amber glass bottles to prevent light degradation. Along the packaging line, every unit is checked against these metrics, because we have seen firsthand how even a tiny slip in purity or moisture control can ruin a researcher’s entire program or slow down a synthesis. Not everyone understands the frustration that follows a failed experiment caused by a contaminated intermediate. Those stories come to us, so we build reliability right into every process step.
Catharanthine acts as one half of the key building blocks for semi-synthetic chemotherapies and anti-cancer compounds. Lab teams use it most often with vindoline to synthesize vinblastine and vincristine. Both have saved countless lives, and both start with the raw materials we supply. In our experience, chemists demand not just chemical purity but also traceability and batch consistency, because regulatory filings and intellectual property rights hinge on reproducibility. When the end products affect patient health, it’s not enough to meet a spec on paper. That’s why our production records stretch back years, linking every batch to its origin point.
In addition to pharmaceutical research, some clients explore catharanthine’s role in biosynthetic studies, metabolic engineering, and alkaloid pathway elucidation. Here, supply stability matters as much as technical performance. Biotech startups and academic labs run on tight funds that leave no room for rescheduling experiments. Delays in delivery—or worse, inconsistent quality—can end promising projects before they even start. This responsibility isn’t lost on our team; constant improvement is our default state, driven by both pride and a keen awareness of the broader impact of our work.
Catharanthine often gets compared to vindoline, tabersonine, and ajmalicine. Each comes from the same plant, but they have different structures and roles in both natural and industrial chemistry. Out of all of them, catharanthine’s value spikes because it enables access to dimeric alkaloids like vincristine, which no synthetic route has yet replaced at scale. Vindoline alone only gets you so far. Neither tabersonine nor ajmalicine can substitute for catharanthine in industrial or lab syntheses aimed at anti-cancer agents. This difference shows up most clearly during conjugation and coupling reactions—steps that make or break a synthesis pipeline.
Lot-to-lot consistency marks another differentiator. Over the years, we have refined our purification to the point where polymorphs and byproducts sit well below threshold limits almost every time. Other producers sometimes cut corners, resulting in fluctuating impurity profiles. Such surprises don’t fit into carefully validated pharmaceutical workflows. We test rigorously for alkaloidal cross-contamination, knowing that even low-level interference can skew final product yields or distort biological screening results.
From a chemical handling perspective, catharanthine’s powder form offers more flexibility compared to viscous or resinous counterparts. This smooth powder measures out easily and dissolves rapidly in typical organic solvents, speeding up both scale-up and microgram-level applications. We’ve calibrated our particle size distribution through fine-mesh filtration to help minimize clumping, allowing for precise dosing every time.
Producing catharanthine in commercial quantities isn’t just about following a published extraction protocol. Plants grow at their own pace, and alkaloid content fluctuates with weather, soil, and harvesting time. We learned early that sourcing reliable Catharanthus roseus matters as much as having the right lab equipment. Our agricultural partners use standardized cultivation and harvest practices, with regular site visits from our staff to confirm everything lines up with our needs. Any slip in quality at this step ripples through the entire process and can take weeks to correct.
The extraction uses gentle techniques that avoid harsh solvents, followed by liquid-liquid partitioning. Each batch sits under constant watch—fluctuations in temperature, solvent purity, or timing can send impurity levels skyrocketing. After extraction, we use multiple crystallizations before subjecting the crude product to column chromatography with tightly controlled flow rates. Documentation tracks every step to ensure nothing falls through the cracks. Analytical runs include HPLC and thin-layer chromatography for each fraction. Often, our operators catch subtle color shifts or crystal habits that indicate the need for extra purification long before a machine flags an anomaly. This “chemical intuition” comes from years of running the lines; it’s hard to teach, but invaluable to our process integrity.
Once the production lot passes all purity and performance checks, drying and packaging follow according to pre-set, monitored parameters. An in-house QA team audits packaging conditions, including relative humidity and temperature, before the material leaves our warehouse. We’ve dealt with issues from inadequate desiccant placement to leaky caps, so nothing leaves the facility without this layer of scrutiny.
We keep up with global regulatory changes, since pharmacological alkaloids like catharanthine attract scrutiny from both customs and pharmaceutical watchdogs. Each export includes a comprehensive certificate of analysis and supply chain record, keyed to the needs of labs from North America to East Asia. We refuse to take shortcuts in documentation, since missing or incomplete paperwork can stall a shipment at the border for weeks, bringing research programs to a grinding halt.
Shipping catharanthine as a high-purity substance brings its own challenges. Unlike more stable compounds, it breaks down under heat, light, and moisture. Every package moves in temperature-controlled containers. For repeat clients, we offer scheduled deliveries to fit their project timelines, a direct response to feedback from R&D project managers who lost valuable time due to late or damaged shipments in the past.
Our technical support does more than answer routine “how-to” questions. Several on our team started in academic research or pharma development, so they speak the language of troubleshooting chromatograms and troubleshooting scale-up failures. Over the years, we have fielded nearly every question about solvent selection, buffer pH range, and storage condition. If someone runs into trouble with a batch—say they see unexpected HPLC peaks or solubility shifts—there’s a direct line to real chemists who have seen many versions of the same problem.
Research settings have taught us that communication gaps kill progress faster than any failed reaction. Our documentation includes guidance on solution preparation, observed physical forms, and tips for handling. If an issue turns up in a client’s workflow, we often run side-by-side studies to help narrow down the culprit, using retained reference samples from every production lot. This hands-on troubleshooting builds trust and shortens the path back to productive research for all involved.
Pharmaceutical innovation shapes the demand for catharanthine year after year. We notice sharp increases in orders when new clinical protocols call for vinblastine analogs or when natural product total synthesis hits the journals. Startups looking into biosynthetic production often use our alkaloid as a standard for metabolic flux studies across yeast or plant cell models. These trends force us to anticipate scaling needs without overshooting inventory or risking product degradation on the shelf.
Feedback loops drive our improvements. Pharmaceutical clients report that our material performs above their minimum spec, especially in terms of stability and solubility across their typical research solvents. Some labs working with other suppliers mention recovery issues or contaminated shipping batches; we review these reports to see where we can do better, even if our own quality scores are high. Occasionally, requests for custom lots—smaller package sizes or unique purity cuts—reach us. Our team reviews the technical feasibility of these requests, weighing them against the realities of bulk production scheduling. Staying flexible keeps both sides in productive partnership.
Over years in production and client support, several pain points come up again and again. Lingering solvent residues, inadequate documentation, and inconsistent quality have derailed research timelines. We target each of these in our daily operations. Solvent analysis forms part of the batch release, flagged not just for EPA or FDA compliance, but for the operational reality of downstream reactions: certain trials fail if trace methanol remains above a few parts per million. Our QC instruments test for these, and our operators keep manual logs as a parallel check; machine data rarely tells the whole story.
Some researchers experience procurement bottlenecks due to erratic delivery schedules or supply interruptions. To address that, we stagger our production runs and maintain strategic stock in multiple shipping hubs. In cases of high seasonal demand, we move to double shifts—something that creates its own headaches in terms of training and oversight, but has proven necessary time and again when innovation cycles spike.
No matter how much upstream process automation we introduce, certain steps in catharanthine production demand hands-on skills. Fraction collection during chromatography, endpoint detection in crystallization, and final drying all benefit from human attention to detail. We invest heavily in training and mentoring new technicians, not just so they memorize steps, but so they learn to spot the early signs of deviation that machines might miss: smell, texture, even subtle color changes under specific lighting can signal a potential problem. This front-line expertise saves batches and builds an institutional memory that serves future production runs.
As pressure grows from environmental regulators, sustainability shapes nearly every operational decision. The natural origin of catharanthine means we keep a close watch on the ecological impact of leaf harvesting. Our supply agreements require sustainable cultivation and fair worker practices. Effluent from extraction and purification passes through a closed treatment loop, with solvent recovery rates rising year by year as we refine both hardware and process steps.
Incineration of non-recoverable waste follows strict documentation, and we regularly run independent audits of emissions and effluent to stay well ahead of regulatory requirements. Internal initiatives target everything from lower water usage to improved energy efficiency in solvent evaporation—a necessary focus since rising costs and environmental standards show no sign of letting up.
No production run is free from obstacles. Supplies of Catharanthus roseus can vary, and extreme weather sometimes threatens harvests. To buffer against these fluctuations, we maintain multiple sourcing partnerships across several continents. Shortfalls in one region can thus be offset elsewhere, which has proven critical during times of regional drought, flooding, or geopolitical instability. On the technical side, contamination from biologically derived extractives continues to challenge our purification protocols. We implement and regularly update advanced analytical controls so that unexpected byproducts rarely reach the packaging stage.
Supply chain resilience also includes scenario planning for transportation interruption—pandemic disruptions highlighted how vulnerable just-in-time manufacturing can be if ports close or air freight is grounded. As a result, we maintain buffer stock and flexible shipment modalities, which help us address urgent orders even during turbulent times.
Looking ahead, we keep our research collaborations open with both academic and industrial partners. Current projects target even higher yields and lower solvent use, with early results showing promise. Automation and digitalization projects have entered our production lines, but never at the expense of core expertise built up over years of hands-on experience. The evolution never stops: with each batch, we record what works, what failed, and where we can improve, feeding this knowledge back into both process and product quality.
Our commitment to catharanthine production is rooted in decades of chemical manufacturing experience. Producing this alkaloid demands technical expertise, logistical care, and constant communication with research and industrial clients. Every improvement, whether in purity, delivery speed, or documentation, reflects accumulated feedback and lessons learned directly from users. We treat feedback both as input for continuous improvement and as evidence of trust earned over many years in the field.
For researchers and manufacturers counting on consistent, reliable catharanthine, our approach minimizes risk and maximizes value. Behind every bottle stands a team deeply dedicated to quality, transparency, and the continuous advancement of chemical manufacturing know-how.